mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.8 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.008 |
0.8 |